Ceftazidime/Avibactam and Meropenem/Vaborbactam for the Management of Enterobacterales Infections: A Narrative Review, Clinical Considerations, and Expert Opinion

• Prif Awduron: Andrea Marino (Awdur), Edoardo Campanella (Awdur), Stefano Stracquadanio (Awdur), Maddalena Calvo (Awdur), Giuseppe Migliorisi (Awdur), Alice Nicolosi (Awdur), Federica Cosentino (Awdur), Stefano Marletta (Awdur), Serena Spampinato (Awdur), Pamela Prestifilippo (Awdur), Stefania Stefani (Awdur), Bruno Cacopardo (Awdur), Giuseppe Nunnari (Awdur)
• Fformat: Llyfr
• Cyhoeddwyd: MDPI AG, 2023-10-01T00:00:00Z.
• Pynciau: article
• Mynediad Ar-lein: Connect to this object online.

This comprehensive review examines the unique attributes, distinctions, and clinical implications of ceftazidime-avibactam (CAZ-AVI) and meropenem-vaborbactam (MEM-VAB) against difficult-to-treat <i>Enterobacterales</i> infections. Our manuscript explores these antibiotics' pharmaco...